Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic

Gregor Rossmueller(Vienna Consulting Engineers (Austria)), Alexander Schinagl(Vienna Consulting Engineers (Austria))

Molecular Cancer Therapeutics

April 17, 2023

10.1158/1535-7163.mct-22-0676

Cited by 17

Related Papers

No related papers found

Powered by citation graph analysis